Professor of Cell and Molecular Biology
Our research aims to understand the cell and molecular biology behind frequent tumour mutations and how they influence cancer onset and/or therapy.
Eyres M. et al, (2021), Gastroenterology
Bangs FK. et al, (2020), Dis Model Mech
Assessment of CCR5/maraviroc immunotherapy in combination with PD1 and MR-guided radiotherapy for treatment of pancreatic cancer.
Hughes S. et al, (2020), CANCER IMMUNOLOGY RESEARCH, 8, 120 - 120
Al-Dalahmah O. et al, (2020), Glia, 68, 435 - 450
Translational analysis from SCALOP trial: CCL5 as a prognostic biomarker and a potentially actionable target in locally advanced pancreatic cancer (LAPC)
Mukherjee S. et al, (2020), JOURNAL OF CLINICAL ONCOLOGY, 38